ALLMedicine™ Brugada Syndrome Center

Sep 28th, 2022 - There have been remarkable advances in our knowledge of the underlying heritability of cardiac arrhythmias. Long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, progressive cardiac conduction disease and the s...

Sep 27th, 2022 - Currently the cornerstone of therapy for ventricular arrhythmic complications and sudden cardiac death prevention in Brugada syndrome (BrS) is an implantable cardioverter defibrillator (ICD). This patients population differs from the majority of p...

Sep 24th, 2022 - The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the transvenous ICD, to prevent lead-related complications associated with the latter. The absence of intravascular or intracardiac components offer...

Sep 23rd, 2022 - Inherited primary arrhythmia syndromes and arrhythmogenic cardiomyopathies can lead to sudden cardiac arrest in otherwise healthy individuals. The burden and expression of these diseases in a real-world, well-phenotyped cardiovascular population i...

Sep 20th, 2022 - Close Relationship Between Severe Pectus Excavatum and Low Voltage Area/Delayed Potentials at Right Ventricular Outflow Tract: Observations in Patient With Brugada Syndrome.|2022|Takahashi M,Abe I,Ishii Y,Kodama N,Hirota K,|

Aug 24th, 2022 - This study will address the hypothesis that re-phenotyping patients with AF and pathogenic arrhythmia/CM variants will identify unrecognized underlying genetic disease. The investigators will recruit from participants sequenced as part of our pros...

Aug 17th, 2022 - It is estimated that approximately 600 apparently fit and healthy individuals aged under 35 years die suddenly in the UK every year Many of these sudden cardiac deaths (SCD) in the young are the result of inherited cardiac conditions (ICC), the ma...

Jul 29th, 2022 - Congestive heart failure (CHF) is a disorder of the heart when structural or functional heart disease impairs the heart's ability to fill with blood or pump it out properly. In developed countries, the prevalence of CHF in the general population i...

Apr 12th, 2022 - This trial aims to develop evidence based curative treatment with optimal net benefit for patients with Brugada syndrome. Since a recent non-randomized pilot study and scarce case reports documented potential clinical benefit of epicardial ablatio...

Apr 12th, 2022 - Brugada syndrome (BrS) patients who undergo BRS substrate ablations from tertiary centers for catheter ablations of complex arrhythmias from three continents - Asia, Europe and North America - are registered in a common database. The investigators...

Dec 17th, 2021 - Despite a flurry of publicity about its newfound cardiac risk profile, the antiseizure medication lamotrigine (Lamictal) is “still a good drug” in epilepsy and an excellent treatment for certain groups, New York University neurologist Jacqueline A.

Nov 4th, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

Nov 4th, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

Jan 28th, 2020 - Genomics experts say evidence falls short for more than half the genes published and anointed as causing long QT syndrome (LQTS) and assessed routinely on commercial genetic test panels. Of the 17 genes previously reported in the literature to cau...

Jan 28th, 2020 - Genomics experts say evidence falls short for more than half the genes published and anointed as causing long QT syndrome (LQTS) and assessed routinely on commercial genetic test panels. Of the 17 genes previously reported in the literature to cau...